Oral Manifestations of COVID-19: A Questionnaire-Based Survey of the Mild and Moderate Cases in the Turkish Population

Author:

Ünallı K. Esra1,Gedik Ecem1,Yazar Ezgi1,Çandırlı Celal1

Affiliation:

1. University of Health Sciences

Abstract

Abstract BACKGROUND A myriad of symptoms associated with COVID-19 have been reported in the literature. It's currently unclear if these symptoms are part of a normal clinical pattern directly induced by SARS-CoV-2 infection or are secondary to the patient's compromised systemic condition, given the probability of coinfections, immunosuppression, and treatment-related adverse effects (4). The aim of this research was to find answers to the question"What is the prevalence of oral symptoms in COVID-19 patients?“. METHODS A questionnaire was designed to detect and identify changes in the oral mucosa in patients with COVID-19 infection. During their follow-up at the Gölcük State Hospital COVID Outpatient Clinic, clinicians and an academic specialist performed a face-to-face survey of the patients. Participants were informed about the purpose of the study and their consent to participate in the study was obtained along with their signatures on the questionnaire form. The data was collected between April 12 and May 22, 2020, and it was analyzed, archived, and processed anonymously. RESULTS This survey included 306 COVID-19 patients in total. The results revealed that only 29.4% of respondents had complaints of oral aphthae and ulcers and 18.94% experienced oral pain; with the most commonly reported symptom being xerostomia (67,6%). There was a widespread distribution of reported symptoms with varying incidences and locations. CONCLUSION Analyzing the data this study procured, one still can’t conclusively determine whether the oral manifestations develop secondary to COVID-19.

Publisher

Research Square Platform LLC

Reference19 articles.

1. 1. CDC. 2019 Novel Coronavirus, Wuhan, China. CDC. https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. 4 Kasım 2021; Erişim Tarihi: 18.03.22

2. 2. Jee Y. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak. Epidemiol Health. 2020;42:e2020013. doi: 10.4178/epih.e2020013. Epub 2020 Mar 19. PMID: 32192278; PMCID: PMC7285442.

3. 3. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 Mar 19;91(1):157–160. doi: 10.23750/abm.v91i1.9397. PMID: 32191675; PMCID: PMC7569573.

4. 4. Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral Manifestations in Patients with COVID-19: A Living Systematic Review. Journal of Dental Research. 2021;100(2):141–154. doi:10.1177/0022034520957289

5. 5. Symptoms of Coronavirus. CDC. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. 22 Şubat 2021; Erişim Tarihi: 18.03.22.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3